This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Clonal hematopoiesis and its emerging effects on cellular therapies
Leukemia Open Access 02 July 2021
-
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
Blood Cancer Journal Open Access 28 April 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tefferi A, Spivak JL . Polycythemia vera: scientific advances and current practice. Seminars Hematol 2005; 42: 206–220.
James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144–1148.
Kralovics R, Guan Y, Prchal JT . Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol 2002; 30: 229–236.
Wang K, Swierczek S, Hickman K, Hakonarson H, Prchal JT . Convergent mechanisms of somatic mutations in polycythemia vera. Discovery Med 2011; 12: 25–32.
Nussenzveig RH, Swierczek SI, Jelinek J, Gaikwad A, Liu E, Verstovsek S et al. Polycythemia vera is not initiated by JAK2V617F mutation. Exp Hematol 2007; 35: 32–38.
Wheeler DA, Wang L . From human genome to cancer genome: The first decade. Genome Res 2013; 23: 1054–1062.
Fisher CL, Pineault N, Brookes C, Helgason CD, Ohta H, Bodner C et al. Loss-of-function additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia. Blood 2010; 115: 38–46.
Stein BL, Williams DM, O'Keefe C, Rogers O, Ingersoll RG, Spivak JL et al. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes. Haematologica 2011; 96: 1462–1469.
Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. New England J Med 2011; 365: 1384–1395.
Rao N, Butcher CM, Lewis ID, Ross DM, Melo JV, Scott HS et al. Clonal and lineage analysis of somatic DNMT3A and JAK2 mutations in a chronic phase polycythemia vera patient. Br J Haematol 2012; 156: 268–270.
Lasho TL, Finke CM, Hanson CA, Jimma T, Knudson RA, Ketterling RP et al. SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients. Leukemia 2012; 26: 1135–1137.
Swierczek SI, Agarwal N, Nussenzveig RH, Rothstein G, Wilson A, Artz A et al. Hematopoiesis is not clonal in healthy elderly women. Blood 2008; 112: 3186–3193.
Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M et al. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. New Engl J Med 1997; 336: 1713–1720.
Prchal JT, Prchal JF, Belickova M, Chen S, Guan Y, Gartland GL et al. Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism. J Exp Med 1996; 183: 561–567.
Prchal JT, Guan YL, Prchal JF, Barany F . Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis. Blood 1993; 81: 269–271.
Jamieson CH, Gotlib J, Durocher JA, Chao MP, Mariappan MR, Lay M et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci USA 2006; 103: 6224–6229.
Acknowledgements
This study was supported by research funding from the National Human Genome Research Institute (NHGRI, grant number: 5U54HG003273) to DW and from the National Institutes of Health (NIH, grant number: NIH-P01CA108671) to JP. We thank Christian Buhay, Donna Morton, Huyen Dinh, Ritika Raj, Lora Lewis, Christie Kovar, Sandra Lee, Michelle Bellair and Zhu Yiming for their excellent technical support.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Wang, L., Swierczek, S., Drummond, J. et al. Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T cells and granulocytes. Leukemia 28, 935–938 (2014). https://doi.org/10.1038/leu.2014.7
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2014.7
This article is cited by
-
Clonal hematopoiesis and its emerging effects on cellular therapies
Leukemia (2021)
-
Polycythemia Vera
Current Treatment Options in Oncology (2018)
-
Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations
Current Hematologic Malignancy Reports (2018)
-
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
Blood Cancer Journal (2017)
-
Familial MPN Predisposition
Current Hematologic Malignancy Reports (2017)